Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
06/2012
06/07/2012US20120139410 Organic electroluminescence device and material for organic electroluminescence device
06/07/2012CA2819734A1 Carbocycle-substituted purine and 7-deazapurine compounds
06/06/2012EP2460794A1 Pharmaceutical composition containing fused hetero-ring derivative
06/05/2012US8193370 Alanine racemase chiral binaphthol derivative with powerful hydrogen bond donor, and optical resolution and optical transformation methods using the same
06/05/2012US8193280 For example, 1,3-bis(glycidyl)imidazolium trifluoromethanesulfonimide; curing with 1,3-bis(3-aminophenoxy)benzene ; adhesives, coatings, composites; high tensile and adhesive strengths at extremely low temperatures and are stable at elevated temperatures; use in harsh environments such as aerospace
06/05/2012US8193231 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193230 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193229 Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors
06/05/2012CA2596013C Benzoimidazole derivatives and pharmaceutical composition comprising the same
05/2012
05/31/2012WO2012070114A1 Sulfamide derivative having npy y5 receptor antagonism
05/31/2012WO2012070069A2 A process for preparation of albendazole
05/31/2012WO2012070068A2 Process for preparation of triclabendazole
05/31/2012WO2012069442A1 Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
05/31/2012WO2012044043A3 Novel method of preparing benzoimidazole derivatives
05/31/2012US20120136002 Protease inhibitors
05/31/2012US20120133274 Carbazole Compound, Light-Emitting Element Material, Organic Semiconductor Material, Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device
05/31/2012US20120132899 Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same
05/31/2012CA2818842A1 Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
05/30/2012EP2457901A1 Benzazole derivatives, compositions, and methods of use as B-secretase inhibitors
05/30/2012EP2456310A1 Substituted benzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiators
05/30/2012CN102482574A 用作场致发光器件的空穴传输材料的菲并唑化合物 Phenanthrene is used as the EL device and a hole transport material azole compound
05/30/2012CN101962367B Method for purifying bendamustine hydrochloride
05/30/2012CN101538193B Method for preparing compounds containing difluoromethyl
05/30/2012CN101389684B Curable epoxy resin composition
05/30/2012CN101090893B New imidazole derivatives, preparation method thereof and organic electronic device using the same
05/29/2012US8188282 Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles
05/29/2012US8188132 Linked dibenzimidazole derivatives
05/29/2012US8187727 Imidazole derivatives, preparation method thereof and organic electronic device using the same
05/29/2012CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same
05/24/2012WO2012068546A1 Heterocycle amines and uses thereof
05/24/2012WO2012065953A1 Substituted carbamoylcycloalkyl acetic acid derivatives as nep inhibitors
05/24/2012US20120126180 Novel materials for organic electroluminescent devices
05/23/2012CN102471269A 含氮杂环衍生物及含有它的有机电致发光元件 Nitrogen-containing heterocyclic derivative and its organic electroluminescence element
05/23/2012CN101203507B 2-substituted benzimidazoles
05/22/2012CA2531064C Novel heteroaryl derivative
05/18/2012WO2012062749A1 Benzimidazolidinones that can be used as fungicides
05/18/2012CA2816000A1 Drug derivatives
05/17/2012US20120122944 Tetrahydronaphthalene derivatives
05/17/2012US20120122137 Novel Nitroreductase Enzymatic Substrates
05/17/2012US20120121536 Compositions and methods for glucose transport inhibition
05/16/2012EP2451944A1 Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
05/16/2012EP1851199B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
05/16/2012DE102007037579B4 Neue Benzimidazol-2-yl-alkylamine und ihre Anwendung als mikrobizide Wirkstoffe New benzimidazol-2-yl-alkylamines and their application as microbicidal agents
05/16/2012CN1854128B Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
05/16/2012CN102459194A Compound having hetero ring skeleton, and process for producing optically active compound using the aforementioned compound as asymmetric catalyst
05/16/2012CN102459193A 抗癌化合物和含有该化合物的药物组合物 Anti-cancer compounds and pharmaceutical compositions containing the compound
05/16/2012CN102452987A Method for preparing amorphous crystalline albendazole
05/16/2012CN102452986A N-formyl hydroxylamine compounds, preparation method thereof, and purposes thereof
05/16/2012CN102452985A Synthesis technology of benzimidazole derivative
05/16/2012CN101247806B SnAr process for preparing benzimidazole compounds
05/15/2012US8178693 N3 alkylated benzimidazole derivatives as MEK inhibitors
05/15/2012US8178672 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 MAP kinase
05/15/2012CA2520714C Process for manufacture of telmisartan
05/15/2012CA2516993C Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
05/15/2012CA2470863C Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
05/10/2012WO2012059935A1 Process for preparing bendamus tine hydrochloride monohydrate
05/10/2012WO2012059443A2 Novel neurotrypsin inhibitors
05/10/2012WO2012059442A2 Neurotrypsin inhibitors
05/10/2012US20120115918 Anti-Viral Compounds
05/10/2012US20120115841 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
05/10/2012US20120111796 Boron Selective Ionic Liquids and Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof
05/09/2012EP2448925A1 Emissive aryl-heteroaryl compounds
05/09/2012CN102442952A Cyclic N-heterocyclic carbene metal complex, and preparation method and application thereof
05/09/2012CN101633644B N3 alkylated benzimidazole derivatives as mek inhibitors
05/08/2012US8173811 Apoptosis promoters
05/03/2012US20120108637 Fused Bicyclic-Substituted Amines as Histamine-3 Receptor Ligands
05/03/2012US20120108573 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
05/02/2012EP2445888A1 Process for preparing telmisartan
05/02/2012EP2445345A1 Benzamide derivatives
05/02/2012EP1955697B1 2-aminobenzamide derivatives as vanilloid receptor 1 (vr1) inhibitors useful for the treatment of pain or bladder function disorder
05/02/2012EP1716851B1 Thioamides and salts thereof and cytokine production inhibitors containing both
05/02/2012EP1647546B1 Novel heteroaryl derivative
05/02/2012EP1606264B1 Monocyclic anilide spirohydantoin cgrp receptor antagonists
05/02/2012CN102438992A Method of inducing cleavage of amyloid precursor protein to form a novel fragment
05/02/2012CN102438660A Imaging agents for detecting neurological disorders
05/02/2012CN101270089B Chromogen containing benzimidazole and synthesizing process
05/02/2012CN101065363B Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
05/01/2012US8168668 Compounds
04/2012
04/26/2012WO2012051708A1 Anti-bacterial pyruvate kinase modulator compounds, compositions, uses, and methods
04/26/2012WO2012028925A3 Process for the preparation of telmisartan
04/26/2012US20120101243 Substituted benzazoloporphyrazines for polymerization and surface attachment and articles formed therefrom
04/25/2012EP2444085A1 Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer
04/25/2012EP2443213A1 Phenanthroazole compounds as hole transporting materials for electro luminescent devices
04/25/2012EP2443094A2 Process for the preparation of telmisartan
04/25/2012EP2260023B1 Fluorene derivatives for organic electroluminescence devices
04/25/2012EP2225210B1 Dual-acting benzoimidazole derivative and their use as antihypertensive agents
04/25/2012CN101899007B 哌嗪化合物 Piperazine compound
04/24/2012US8163935 Fused heterocyclic compounds
04/24/2012US8163919 Imidazopyridinyl benzamide mitotic kinesin inhibitors
04/24/2012US8163751 Acylated indanyl amines and their use as pharmaceuticals
04/24/2012CA2538743C Benzylbenzimidazolyl derivatives as kinase inhibitors
04/19/2012WO2012051551A1 N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
04/19/2012US20120095227 Compound having hetero ring skeleton, and process for producing optically active compound using the aforementioned compound as asymmetric catalyst
04/19/2012US20120095049 Nociceptin analogs
04/19/2012US20120094977 Compositions and methods for the treatment of disease associated with trp-p8 expression
04/18/2012EP2440295A1 Benzimidazole derivatives useful as trpm8 channel modulators
04/18/2012EP2440294A1 Benzimidazole derivatives useful as trpm8 channel modulators
04/18/2012EP2176235B1 A method of manufacturing 4'-[[4-methyl-6-(1-methyl-1h-benzimidazol-2-yl)-2-propyl-1h-benzimidazol-1yl]methyl]biphenyl-2-carboxylic acid (telmisartan)
04/18/2012EP1569919B1 Non-nucleoside reverse transcriptase inhibitors
04/18/2012CN102417484A 因子VIIa抑制剂 Factor VIIa inhibitors
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 154